Exact Mass: 345.0671

Exact Mass Matches: 345.0671

Found 39 metabolites which its exact mass value is equals to given mass value 345.0671, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

EP_M346

C17H13ClFN3O2 (345.068)

CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2201

(R)-METHYL 5-AMINO-3-(1-(2-(TRIFLUOROMETHYL)PHENYL)ETHOXY)THIOPHENE-2-CARBOXYLATE

C15H14F3NO3S (345.0646)

3,3-Diphenyltetrahydrofuran-2-ylidene(dimethyl)ammonium bromide

C18H20BrNO (345.0728)

Fmoc-beta-chloro-L-alanine

C18H16ClNO4 (345.0768)

(s)-(+)-n-(3,5-dinitrobenzoyl)-alpha-phenylglycine

C15H11N3O7 (345.0597)

2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine

C13H10F3N3O5 (345.0573)

5-methoxy-1-(4-methoxyphenyl)sulfonylindole-3-carbaldehyde

C17H15NO5S (345.0671)

(2R)-Amino(3,5-dinitrophenyl)acetic acid

C15H11N3O7 (345.0597)

(E)-3-(4-fluorophenyl)-N-[(pyrazine-2-carbonylamino)carbamothioyl]prop-2-enamide

C15H12FN5O2S (345.0696)

methyl 2-[4-(4-chlorobenzoyl)-3,4-dihydro-2H-1,4-benzoxazin-3-yl]acetate

C18H16ClNO4 (345.0768)

N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide

C15H15N5OS2 (345.0718)

4-(4-chlorophenyl)-N-[2-(5-methyl-1H-imidazol-2-yl)ethyl]thiophene-2-carboxamide

C17H16ClN3OS (345.0703)

2-[3-(7-bromo-9H-pyrido[3,4-b]indol-1-yl)propyl]guanidine

C15H16BrN5 (345.0589)

1-{[(2R,3S)-3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-3-ol

C17H13ClFN3O2 (345.068)

Syringetin(1-)

C17H13O8- (345.061)

The 3-oxoanion of syringetin.

Adenosine 5-phosphoramidate(1-)

C10H14N6O6P- (345.0712)

Conjugate base of adenosine 5-phosphoramidate; major species at pH 7.3.

4,5,7-Trihydroxy-3,6-dimethoxyflavonol

C17H13O8- (345.061)

3,3-Dimethylmyricetin

C17H13O8- (345.061)

4,5,7-trihydroxy-3,8-dimethoxyflavonol

C17H13O8- (345.061)

3,4-Dimethylmyricetin

C17H13O8- (345.061)

2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-4H-chromen-4-one

C17H13O8- (345.061)

3-amino-3-deoxyAMP

C10H14N6O6P- (345.0712)

3-Phenyl-N-[N-(2-thiophen-2-yl-acetyl)-hydrazinocarbothioyl]-acrylamide

C16H15N3O2S2 (345.0606)

2-(2-oxo-1,3-benzothiazol-3-yl)-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide

C16H15N3O2S2 (345.0606)

3,4,5,6-Tetrahydroxy-3,7-dimethoxyflavone(1-)

C17H13O8- (345.061)

6-[(2,4-Difluorophenyl)methyl]-2,4-dimethyl-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone

C17H13F2N3OS (345.0747)

6-[(2,5-Difluorophenyl)methyl]-2,4-dimethyl-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone

C17H13F2N3OS (345.0747)

2-(1-Iminoethyl)-4-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-3-oxobutanenitrile

C15H15N5OS2 (345.0718)

VU10010

C17H16ClN3OS (345.0703)

VU10010 is a potent, highly selective and allosteric M4 mAChR potentiator with an EC50 of 400 nM. VU10010 binds to an allosteric site on M4 mAChR and increases affinity for acetylcholine and coupling to G proteins. VU10010 increases carbachol-induced depression of transmission at excitatory but not inhibitory synapses in the hippocampus[1].

19-methoxy-3,5-dioxa-11-azahexacyclo[9.9.2.0²,⁶.0⁸,²¹.0¹⁴,²².0¹⁵,²⁰]docosa-1,6,8(21),9,14(22),15(20),16,18-octaene-12,13-dione

C20H11NO5 (345.0637)

n-(3-{7-bromo-9h-pyrido[3,4-b]indol-1-yl}propyl)guanidine

C15H16BrN5 (345.0589)